查找临床试验
已按「遗传性视网膜病变」检索，对应国际通用词 inherited retinal disease
共找到 23 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:25，每 5 分钟自动同步Pilot Study of AuTNA I
China
年龄 18 Years – 70 Years
Eye & ENT Hospital of Fudan University
Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy
China
年龄 8 Years – 45 Years
Peking Union Medical College Hospital
Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)
China
年龄 6 Years – 不限
VeonGen Therapeutics GmbH
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
China
年龄 18 Years – 不限
Zhongshan Ophthalmic Center, Sun Yat-sen University
Topotecan and Melphalan for Retinoblastoma
China
年龄 不限 – 不限
Sun Yat-sen University
Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
China
年龄 18 Years – 55 Years
Peking Union Medical College Hospital
Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
China
年龄 18 Years – 不限
Chigenovo Co., Ltd
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
China
年龄 6 Months – 不限
Eye & ENT Hospital of Fudan University
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Taiwan
年龄 0 Years – 18 Years
Chang Gung Memorial Hospital
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
United States、Australia、China
年龄 18 Years – 65 Years
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
Natural History Study of Inherited Retinal Diseases
China
年龄 不限 – 不限
Zhongmou Therapeutics
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
China
年龄 不限 – 不限
Wang Yusheng